• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1100198 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Import Drug Application 2011-06-24 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2013-05-28 view
CXHL1100682 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2012-01-11 南京华威医药科技开发有限公司 Nanjing Huawei Medicine Technology Development Co Ltd Certificate Issued 2014-01-21 view
CXHL1200517 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2012-11-15 北京福瑞康正医药技术研究所 Beijing Furuikangzheng Medicine Technology Research Institute Certificate Issued 2015-11-05 view
CXHL1200776 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2012-12-19 江苏豪森药业股份有限公司 Jiangsu Hansoh Pharmaceutical Group Co Ltd Certificate Issued 2015-09-08 view
CXHL1300476 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2013-08-07 山东创新药物研发有限公司 Shandong Innovative Drug Research and Development Co Ltd Certificate Issued 2015-12-30 view
JXHL1300390 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Import Drug Application 2013-10-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2014-09-10 view
CXHB1400015 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Supplementary Application 2014-05-20 成都百裕科技制药有限公司 Chengdu Baiyu Pharmaceutical Co Ltd Certificate Issued 2014-11-21 view
CXHL1401070 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2014-09-28 中国人民解放军军事医学科学院毒物药物研究所 Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA Certificate Issued 2016-03-16 view
CXHL1401601 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2014-12-19 东莞市长安东阳光药物研发有限公司 Dongguan HEC Pharm R&D Co Ltd Accepted 2014-10-22 view
CXHL1501200 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(3.1) New Drug Application 2015-07-09 浙江华海药业股份有限公司 Zhe JIANG HUA HAI Pharmaceutical Co Ltd Certificate Issued 2016-08-12 view
JXHS1900046 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(5.1) Import Drug Application 2019-04-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2019-07-16 view
JYHB1900958 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Supplementary Application 2019-08-07 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2019-08-16 view
JYHB1900987 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(5.1) Supplementary Application 2019-08-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2019-09-06 view
JYHB1900966 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(5.1) Supplementary Application 2019-08-12 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2019-08-28 view
JYHF1900139 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Supplementary Application 2019-09-19 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Certificate Issued 2019-10-17 view
JYHB1901178 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(5.1) Supplementary Application 2019-09-29 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2019-10-14 view
CYHS2000114 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(4) Generic Drug 2020-02-26 广东东阳光药业有限公司 Sunshine Lake Pharma Co Ltd In Review 2020-02-25 view
JYHB2000808 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Supplementary Application 2020-06-12 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2020-06-19 view
JYHB2000989 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs Supplementary Application 2020-06-25 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd Filed 2020-06-29 view
JYHB2100123 盐酸芬戈莫德胶囊 fingolimod hydrochloride Capsule Chemical Drugs(5.1) Supplementary Application 2021-02-05 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd In Review 2021-02-05 view